SRRK

49.0102.70%
JS

Jeffrey S. Flier

Independent Director & Member of Scientific Advisory Board

Dr. Jeffrey S. Flier, M.D., Ph.D. also known as Jeff, serves as Advisor at Lauxera Capital Partners, and serves as Vice Chairman of Research of the Department of Medicine at BIDMC. Dr. Flier served as Director at Sigilon Therapeutics, Inc. since 2019 until June 10, 2020. He served as Dean of Harvard Medical School from September 1, 2007 to 2016. Dr. Flier served as Chief Academic Officer of Beth Israel Deaconess Medical Center (BIDMC). He serves as a George C. Reisman Professor of Medicine at Harvard Medical School. He served as Division Chief of Endocrinology at BIDMC. He serves as a Co-Chairman and Member of the Scientific Advisory Board at Alinea Pharmaceuticals, Inc. He has been a Director and Member of Scientific Advisory Board of Scholar Rock, Inc. since November 22, 2016. He has been a Director and Member of Scientific Advisory Board of Scholar Rock Holding Corporation since October 2016. Dr. Flier serves as a Director of Broad Institute of MIT and Harvard. He serves as a Member of Medical Advisory Board at Gairdner Foundation. He serves as a Member of the Scientific Advisory Board at Cantata Laboratories Inc. He serves as a Member of Scientific Advisory Board at Elixir Pharmaceuticals, Inc. Dr. Flier serves as a Member of Advisory Board at MDPad Corporation. He serves as on the Board of Consulting Editors of Science Magazine. He served as a Scientific Advisor of RDAB Board of BG Medicine, Inc. He served many editorial positions, including Associate Editor of the Journal of Clinical Investigation and served on the Editorial Boards of Molecular Endocrinology, the Journal of Clinical Endocrinology and Metabolism and the American Journal of Medicine. Dr. Flier received numerous honors and awards, including the recipient of the 2005 Banting Medal from the American Diabetes Association, its highest scientific honor. He is a Member of the Institute of Medicine of the National Academy of Arts and Sciences. His research has produced major insights into the molecular mechanism of insulin action, the molecular mechanisms of insulin resistance in human disease and the molecular pathophysiology of obesity. He has authored over 200 scholarly papers and reviews. He did his residency training at Mount Sinai Hospital. Dr. Flier was a clinical associate at the National Institutes of Health (NIH) and then joined the faculty of medicine at Harvard Medical School. Dr. Flier is a BS of the City College of New York and Mount Sinai School of Medicine and MD from Mount Sinai School of Medicine with highest academic honors.

Positions